Inventor · disambiguated record
Julian Blagg
Also filed as: BLAGG JULIAN
29 granted patents·7 pending applications·187 citations·filing 1993–2022
96Inventor score
Top patents by PatentIndex Score
36 records- 0193US11897877B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2021·Granted Feb 13, 2024·2 cites·17 claims
- 0292US9409907B2Inhibitor compoundsCANCER RES TECH LTD·Filed 2013·Granted Aug 9, 2016·14 cites·2 claims
- 0391US9890157B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Feb 13, 2018·10 cites·15 claims
- 0491US9834552B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Dec 5, 2017·8 cites·8 claims
- 0588US11046688B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2019·Granted Jun 29, 2021·2 cites·19 claims
- 0686US10479788B2Compounds that inhibit MPS1 kinaseCANCER RESEARCH TECH LTD·Filed 2018·Granted Nov 19, 2019·4 cites·19 claims
- 0786US9902721B2N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitorsCANCER RESEARCH TECH LTD·Filed 2015·Granted Feb 27, 2018·7 cites·13 claims
- 0886US8778925B2Pyridine and pyrimidine based compounds as Wnt signaling pathway inhibitors for the treatment of cancerMCDONALD EDWARD·Filed 2009·Granted Jul 15, 2014·11 cites·11 claims
- 0982US10399974B2N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitorsCANCER RESEARCH TECH LTD·Filed 2018·Granted Sep 3, 2019·3 cites·4 claims
- 1082US9371319B2Pyrrolopyridineamino derivatives as MPS1 inhibitorsBAVETSIAS VASSILIOS·Filed 2012·Granted Jun 21, 2016·8 cites·18 claims
- 1180US10501462B2Pyrrolo[3,2-c]pyridine-6-amino derivativesCANCER RESEARCH TECH LTD·Filed 2016·Granted Dec 10, 2019·3 cites·10 claims
- 1280US9334286B2Pharmacologically active compoundsCANCER REC TECH LTD·Filed 2013·Granted May 10, 2016·4 cites·17 claims
- 1379US6180627B1Antithrombotic agentsPFIZER·Filed 1999·Granted Jan 30, 2001·55 cites·29 claims
- 1475US6579982B1Pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2000·Granted Jun 17, 2003·10 cites·34 claims
- 1574US9169234B2Sepiapterin reductase inhibitors for the treatment of painBLAGG JULIAN·Filed 2010·Granted Oct 27, 2015·4 cites·16 claims
- 1673US6949577B2PharmaceuticalsPFIZER·Filed 2003·Granted Sep 27, 2005·6 cites·24 claims
- 1771US9895364B2Pharmacologically active compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Feb 20, 2018·1 cites·15 claims
- 1870US6936619B2Quinazolinone compounds useful in therapyPFIZER·Filed 2003·Granted Aug 30, 2005·7 cites·16 claims
- 1970US6417203B1Antithrombotic agentsPFIZER·Filed 2000·Granted Jul 9, 2002·5 cites·28 claims
- 2066US7928099B2Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonistsPFIZER·Filed 2008·Granted Apr 19, 2011·1 cites·11 claims
- 2165US9447092B2Pharmaceutically active compoundsCANCER RES TECH LTD·Filed 2013·Granted Sep 20, 2016·1 cites·9 claims
- 2263US9834541B22-aminopyridine compoundsMERCK PATENT GMBH·Filed 2013·Granted Dec 5, 2017·1 cites·7 claims
- 2356US5767139AIndoles which have steroid 5-α reductase inhibitory activityPFIZER·Filed 1993·Granted Jun 16, 1998·13 cites·14 claims
- 2455US2024425453A1Isoindolines as pms2 inhibitorsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 2555US2014350015A1Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancerCANCER REC TECH LTD·Filed 2014·Application pending·0 cites
- 2655US2024425483A1Indolines as protac compoundsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 2754US10188642B2Pharmacologically active compoundsCANCER RESEARCH TECH LTD·Filed 2017·Granted Jan 29, 2019·0 cites·15 claims
- 2853US2024293392A1Inhibitor compoundsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 2949US10059664B2Sepiapterin reductase inhibitors for the treatment of painCHILDRENS MEDICAL CENTER·Filed 2015·Granted Aug 28, 2018·0 cites·19 claims
- 3045US5912357AIndole derivatives as 5-α-reductase-1-inhibitorsPFIZER·Filed 1994·Granted Jun 15, 1999·5 cites·9 claims
- 3139US5696146AIndole derivatives as steroid 5α-reductase inhibitorsPFIZER·Filed 1994·Granted Dec 9, 1997·2 cites·8 claims
- 3238US2002147229A1PharmaceuticalsFiled 2001·Application pending·0 cites
- 3331US5922747AIndole derivatives as steroid 5α-reductase inhibitorsPFIZER·Filed 1997·Granted Jul 13, 1999·0 cites·3 claims
- 3431US2012252791A1Heterocyclic GTP Cyclohydrolase 1 Inhibitors For the Treatment of PainBLAGG JULIAN·Filed 2010·Application pending·0 cites
- 3529US9926319B2Pyridyl piperidinesMERCK PATENT GMBH·Filed 2015·Granted Mar 27, 2018·0 cites·8 claims
- 3629US2016016951A1Novel naphthyridines and isoquinolines and their use as cdk8/19 inhibitorsMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julian Blagg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →